Literature DB >> 27582061

Origin of the U87MG glioma cell line: Good news and bad news.

Marie Allen1, Mia Bjerke2, Hanna Edlund3, Sven Nelander1, Bengt Westermark4.   

Abstract

Human tumor-derived cell lines are indispensable tools for basic and translational oncology. They have an infinite life span and are easy to handle and scalable, and results can be obtained with high reproducibility. However, a tumor-derived cell line may not be authentic to the tumor of origin. Two major questions emerge: Have the identity of the donor and the actual tumor origin of the cell line been accurately determined? To what extent does the cell line reflect the phenotype of the tumor type of origin? The importance of these questions is greatest in translational research. We have examined these questions using genetic profiling and transcriptome analysis in human glioma cell lines. We find that the DNA profile of the widely used glioma cell line U87MG is different from that of the original cells and that it is likely to be a bona fide human glioblastoma cell line of unknown origin.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27582061     DOI: 10.1126/scitranslmed.aaf6853

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  149 in total

1.  EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma.

Authors:  Zhenyi An; Christiane B Knobbe-Thomsen; Xiaohua Wan; Qi Wen Fan; Guido Reifenberger; William A Weiss
Journal:  Cancer Res       Date:  2018-11-06       Impact factor: 12.701

2.  Cancer therapy: Neutrophils traffic in cancer nanodrugs.

Authors:  Satoru Osuka; Erwin G Van Meir
Journal:  Nat Nanotechnol       Date:  2017-06-19       Impact factor: 39.213

3.  The Tumorgenicity of Glioblastoma Cell Line U87MG Decreased During Serial In Vitro Passage.

Authors:  Yu Zeng; Xizhao Wang; Jizhou Wang; Renhui Yi; Hao Long; Mingfeng Zhou; Qisheng Luo; Zhihao Zhai; Ye Song; Songtao Qi
Journal:  Cell Mol Neurobiol       Date:  2018-06-08       Impact factor: 5.046

4.  miR-204 functions as a tumor suppressor gene, at least partly by suppressing CYP27A1 in glioblastoma.

Authors:  Jun Xin; Li-Min Zheng; De-Ke Sun; Xian-Feng Li; Peng Xu; Li-Qiang Tian
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

5.  Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma.

Authors:  Rachael A Vaubel; Shulan Tian; Dioval Remonde; Mark A Schroeder; Ann C Mladek; Gaspar J Kitange; Alissa Caron; Thomas M Kollmeyer; Rebecca Grove; Sen Peng; Brett L Carlson; Daniel J Ma; Gobinda Sarkar; Lisa Evers; Paul A Decker; Huihuang Yan; Harshil D Dhruv; Michael E Berens; Qianghu Wang; Bianca M Marin; Eric W Klee; Andrea Califano; Daniel H LaChance; Jeanette E Eckel-Passow; Roel G Verhaak; Erik P Sulman; Terry C Burns; Fredrick B Meyer; Brian P O'Neill; Nhan L Tran; Caterina Giannini; Robert B Jenkins; Ian F Parney; Jann N Sarkaria
Journal:  Clin Cancer Res       Date:  2019-12-18       Impact factor: 12.531

6.  Targeting VPAC1 Receptors for Imaging Glioblastoma.

Authors:  Sushil K Tripathi; Rhonda Kean; Emily Bongiorno; Douglas C Hooper; Yuan-Yuan Jin; Eric Wickstrom; Peter A McCue; Mathew L Thakur
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

7.  MicroRNA-370 suppresses the progression and proliferation of human astrocytoma and glioblastoma by negatively regulating β-catenin and causing activation of FOXO3a.

Authors:  Ming Lu; Yong Wang; Shizhen Zhou; Jun Xu; Jing Li; Rongjie Tao; Yufang Zhu
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

8.  Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells.

Authors:  Fernando Francisco Borges Resende; Simoneide Souza Titze-de-Almeida; Ricardo Titze-de-Almeida
Journal:  Oncol Lett       Date:  2018-02-01       Impact factor: 2.967

9.  MAP30 promotes apoptosis of U251 and U87 cells by suppressing the LGR5 and Wnt/β-catenin signaling pathway, and enhancing Smac expression.

Authors:  Yilin Jiang; Junjie Miao; Dongliang Wang; Jingru Zhou; Bo Liu; Feng Jiao; Jiangfeng Liang; Yangshuo Wang; Cungang Fan; Qingjun Zhang
Journal:  Oncol Lett       Date:  2018-02-16       Impact factor: 2.967

10.  Mutation Profiles in Glioblastoma 3D Oncospheres Modulate Drug Efficacy.

Authors:  Kelli M Wilson; Lesley A Mathews-Griner; Tara Williamson; Rajarshi Guha; Lu Chen; Paul Shinn; Crystal McKnight; Sam Michael; Carleen Klumpp-Thomas; Zev A Binder; Marc Ferrer; Gary L Gallia; Craig J Thomas; Gregory J Riggins
Journal:  SLAS Technol       Date:  2018-10-05       Impact factor: 3.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.